Charles River Laboratories (CRL +6.4%) and Wuxi PharmaTech (WX) call off their merger agreement following continued investor opposition. The $1.6B deal would have been the largest foreign takeover of a Chinese company; instead, Charles River will pay Wuxi a $30M breakup fee and begin a $500M share buyback program. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (Jan 14, 2015)
at CNBC.com (Oct 30, 2014)
at CNBC.com (Aug 12, 2014)
at CNBC.com (Mar 18, 2014)
at CNBC.com (Dec 3, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs